Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 09-1999 | 06-1999 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 4,120 | N/A | N/A |
| Receivables | 80 | N/A | N/A |
| Other current assets | 170 | 0 | 0 |
| TOTAL | $4,370 | $N/A | $N/A |
| Non-Current Assets | |||
| Investments And Advances | 60 | 0 | 0 |
| Other Non-Current Assets | 340 | 0 | 0 |
| TOTAL | $400 | $N/A | $N/A |
| Total Assets | $4,940 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 250 | 0 | 0 |
| Other current liabilities | 140 | N/A | N/A |
| TOTAL | $390 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 110 | 0 | 0 |
| TOTAL | $110 | $N/A | $N/A |
| Total Liabilities | $510 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | N/A | N/A |
| Retained earnings | -12,420 | N/A | N/A |
| Other shareholders' equity | -2,861 | 0 | 0 |
| TOTAL | $4,430 | $N/A | $N/A |
| Total Liabilities And Equity | $4,940 | $0 | $0 |